MedTrace Logo

Evaluation of Human Papillomavirus Vaccine Coverage in Girls and Young Women With Chronic Disease

NCT06158802 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 223

Last updated 2025-11-20

No results posted yet for this study

Summary

The main objective of the study is to determine the vaccination coverage rate for human papillomavirus in adolescents aged 11 to 20 with chronic disease and treated at the Necker-Enfants Malades Hospital, compared to a population witnessed adolescent girls aged 11 to 20 years without chronic disease.

Conditions

  • Human Papillomavirus Vaccine
  • Chronic Condition

Interventions

OTHER

Questionnaire

Questionnaire on human papillomavirus vaccine status of girls and young women and modalities of the vaccination or reason of the non-vaccination. The questionnaire is completed by the patient.

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Sabrina DA COSTA, MD · Assistance Publique - Hôpitaux de Paris

  • Alaa CHEIKHELARD, MD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
11 Years
Max Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-23
Primary Completion
2025-06-26
Completion
2025-06-26

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06158802 on ClinicalTrials.gov